In vitro activity of imipenem-relebactam against carbapenem-resistant Pseudomonas aeruginosa: correlation with carbapenem MICs and association with β-lactamase classes
{{output}}
Introduction: Carbapenem-resistant P. aeruginosa (CRPA) poses a major therapeutic challenge due to the limited number of available treatment options. Imipenem-relebactam (IMP-REL), a carbapenem combined with a Class A/C β-lactam... ...
